← FDA DRUG APPROVALS

FDA ANDA · ANDA206959

ADAPALENE AND BENZOYL PEROXIDE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA206959
TYPE
ANDA
ORIGINAL APPROVAL
2018-01-24
LATEST ACTION
2018-01-24
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription

Products

ADAPALENE AND BENZOYL PEROXIDEPrescription
ADAPALENE 0.1%, BENZOYL PEROXIDE 2.5% · GEL · TOPICAL

Approval history

2018-01-24UNKNOWN · Original · standard — Letter ↗AP
2018-01-24Labeling · Original · standard — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →